Cathy Raymond, assistant director of English Language Programs, doesn’t just help international students at WashU improve their English. She also works abroad building connections and helping improve lives through education.
After graduating from the Washington University–Fudan University joint Executive MBA, Paul Shao EMBA ’13, became the program’s managing director. Now he’s trying to grow the program’s reputation even further in China.
When Kevin Xu wanted to learn an American style of management in order to grow his company, RUIChem, he turned to the Olin Business School–Fudan University’s Executive MBA program.
What do you do if you are trying to save a very rare and shy animal? How do you even find them? Anthropologist Joseph Orkin, PhD ’14, called in Pinkerton. No, not the detective agency, the dog.
Shashikant Kulkarni, PhD, an associate professor of pathology and immunology at the School of Medicine, has been named editor-in-chief of the journal Cancer Genetics.
Melody Goodman, PhD, an assistant professor of surgery at Washington University School of Medicine and a research member of Siteman Cancer Center, has been appointed to the City of St. Louis Board of Health and Hospitals.
The Friday, Dec. 4, meeting of the Washington University in St. Louis Board of Trustees focused on graduate and professional education, according to Chancellor Mark S. Wrighton. The board also elected a new trustee. Distinguished alumnus F. Gilbert Bickel III (BSBA ’66), a senior vice president with Wells Fargo Advisors, was elected as a new Ethan A.H. Shepley Trustee.
It’s a response made all too often by politicians in the wake of a mass shooting or violent act of terrorism: Keeping all in “thoughts and prayers.” This week, in the wake of the Dec. 2 shooting incident in San Bernardino, Calif., that sentiment seemed to reached a breaking point and shed light on the wide political and rhetorical chasm dividing the country, said John Inazu, JD, an expert on law and religion at Washington University in St. Louis.
Researchers at the School of Medicine have been awarded $13.7 million from the National Cancer Institute (NCI) to create new therapies for multiple myeloma, a cancer of the immune system. Led by Samuel Achilefu, PhD, (pictured) and Gregory Lanza, MD, PhD, at the newly created Center for Multiple Myeloma Nanotherapy, scientists will work to develop nanomaterials and drugs to treat the disease.
Emil R. Unanue, MD, an internationally renowned immunologist at the School of Medicine, has received a Sanofi-Institut Pasteur Award for his invaluable contributions to the field of immunology. The annual awards honor scientists who have made outstanding contributions to biomedical research in fields that profoundly affect global health.
